MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. BOSTON, Dec. 6, 2025... Read more.
Zenocutuzumab-zbco (BIZENGRI®) Shows Durable Efficacy in Patients with Treatment-Naïve NRG1+NSCLC: Updated eNRGy Trial Results Presented at IASLC-ASCO NACLC
LEXINGTON, Mass., Dec. 6, 2025 /PRNewswire/ — Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company, announced new data from... Read more.
Best HR and Payroll Software (2025): QuickBooks Awarded for Accuracy and Team Management by Better Business Advice
NEW YORK , Dec. 6, 2025 /PRNewswire/ — Better Business Advice has recognized QuickBooks as the Best HR and Payroll Software (2025) for its accuracy, team... Read more.
Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
New long-term data presented at AES 2025 indicate reductions in seizure frequency are maintained for up to two years after treatment initiation with bexicaserin... Read more.
Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin’s Lymphoma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 6, 2025 /PRNewswire/ — Vivacta Bio, a spin-off company of Grit Biotherapeutics advancing in vivo CAR-T therapies for oncology and autoimmune... Read more.
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions... Read more.
Advances in Technology Help Improve Safety and Access to Blood Cancer Therapies
Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patients ORLANDO, Fla., Dec. 6, 2025 /PRNewswire/ — Four clinical... Read more.
MemeMax, MemeCore’s First Perp DEX, Extends MaxPack Event Ahead of January Launch After 400% Network Surge
SEOUL, South Korea, Dec. 6, 2025 /PRNewswire/ — MemeMax, the first Perp DEX built within the MemeCore ecosystem, has extended its ‘MaxPack Airdrop Campaign’... Read more.
PCs for People Announces Departure of Cofounder and CEO Casey Sorensen After 18 Years of Leadership
ST. PAUL, Minn., Dec. 5, 2025 /PRNewswire/ — PCs FOR PEOPLE announced today that Cofounder and CEO, Casey Sorensen, is departing from his role effective December... Read more.
TODAY SHOW EXPOSES AI MEDICAL SCAMS TARGETING LIPEDEMA PATIENTS
LOS ANGELES, Dec. 5, 2025 /PRNewswire/ — AI-generated deepfake scams are rapidly spreading across social media, using fabricated videos, synthetic voices,... Read more.